For press requests, please contact agross@economicliberties.us


Court Must Reject Weak Visa–Mastercard Settlement That Fails to Curb Market Power, Congress Should Pass CCCA

November 10, 2025 – Following a reported settlement Visa and Mastercard have with merchants in a private antitrust case alleging the duopoly uses its market power to centrally price-fix swipe fees charged by banks that issue cards under their brand, the American Economic Liberties Project released the following statement urging the rejection of the settlement. 

Economic Liberties Applauds Medicare’s 2026 Physician Fee Schedule

November 7, 2025 – In response to the Centers for Medicare and Medicaid Services (CMS) issuing its final 2026 Medicare physician fee schedule, the American Economic Liberties Project released the following statement.

Sweeping New Powers for Presidents to Reward Allies and Punish Enemies Worldwide at Stake as Supreme Court Takes Up Tariffs Case Tomorrow

November 4, 2025 – Ahead of tomorrow’s Supreme Court oral argument in the cases challenging President Donald Trump’s authority to impose broad tariffs, Rethink Trade today released a new analysis warning that a ruling in the administration’s favor would authorize immense unilateral powers for presidents to use tariffs to reward or punish specific companies, economic sectors, and entire countries.

Cigna’s Rebate-Free Pharmacy Model Is a Red Herring

November 3, 2025 – Following news that insurance conglomerate Cigna Group, which owns the second-largest pharmacy benefit manager (PBM) Express Scripts, will transition to a rebate-free business model, the American Economic Liberties Project released the following statement.

There Are No Good Buyers in a Potential Netflix-Warner Bros.-Paramount Deal

October 31, 2025 – Following news that Netflix is reportedly “actively pursuing” an acquisition of Warner Bros. Discovery, joining Paramount-Skydance — President Trump’s preferred buyer of the media giant — the American Economic Liberties Project released the following statement.